Get started
Author

Katie J. Anderson

Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a–C3aR interaction
2007 · Qi Peng, Ke Li, et al. · Blood · 179
Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre
2017 · Victoria M. W. Gould, James N. Francis, et al. · Frontiers in Microbiology · 128
PDF
Cyclic AMP plays a critical role in C3a-receptor–mediated regulation of dendritic cells in antigen uptake and T-cell stimulation
2008 · Ke Li, Katie J. Anderson, et al. · Blood · 127
The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
2021 · Kirsten S. Vannice, Susan L. Hills, et al. · npj Vaccines · 98
PDF
Regulation of T‐cell immunity by leucocyte immunoglobulin‐like receptors: innate immune receptors for self on antigen‐presenting cells
2009 · Katie J. Anderson, Rachel L. Allen · Immunology · 90
The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
2009 · Damien P Brown, Des C Jones, et al. · BMC Immunology · 64
PDF
Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB
2024 · Won Young Tak, Wan-Lobg Chuang, et al. · Journal of Hepatology · 58
Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial
2021 · Sybil Tasker, Anna Wight O’Rourke, et al. · Vaccines · 31
PDF
Intravenous administration of viral vectors expressing prostate cancer antigens enhances the magnitude and functionality of CD8+ T cell responses
2022 · Antonella Vardeu, Charlotte Davis, et al. · Journal for ImmunoTherapy of Cancer · 17
PDF
OS-031 Imdusiran (AB-729) administered every 8 weeks for 24 weeks followed by the immunotherapeutic VTP-300 maintains lower HBV surface antigen levels in NA-suppressed CHB subjects than 24 weeks of imdusiran alone
2024 · Kosh Agarwal, Man-Fung Yuen, et al. · Journal of Hepatology · 8
Phase 1b/2a study of heterologous ChAdOx1-HBV/MVA-HBV immunotherapy (VTP-300) combined with low-dose nivolumab (LDN) in virally suppressed patients with CHB on nucleos (t)ide analogues
2023 · Tom Evans, Eleanor Barnes, et al. · Journal of Hepatology · 3
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-risk Human Papillomavirus Vaccine in Women With Low-grade Cervical Lesions
2025 · Karin Hellner, Philippe Simon, et al. · Clinical Infectious Diseases · 2
PDF
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
2024 · Charlotte Davis, Dave Singh, et al. · Vaccines · 2
LBP-004 Primary analysis of a phase 2b open-label study demonstrates VTP-300 administered with low-dose nivolumab is associated with meaningful reductions of HBsAg in chronic hepatitis B participants with HBsAg less than 200 IU/mL
2025 · Man-Fung Yuen, Wan-Long Chuang, et al. · Journal of Hepatology · 1
Abstract 720: Combining zelasudil, a small molecule ROCK2 inhibitor, with chemotherapy or immunotherapy improves response in preclinical models of pancreatic cancer
2024 · Marina Pajic, Benjamin McLean, et al. · Cancer Research · 1
Prime-boost immunotherapeutic trial in men with biochemical recurrence after definitive local therapy for prostate cancer.
2023 · Mark N. Stein, Jessica E. Hawley, et al. · Journal of Clinical Oncology · 1
Exploration of mechanisms by which production of C3 by dendritic cells (DCs) modulates their function of antigen presentation
2007 · Katie Anderson, Qi Peng, et al. · Molecular Immunology · 1
WED-375 VTP-300 immunotherapeutic, plus low dose PD-1 inhibitor, nivolumab, continues to show meaningful, sustained reductions in HBsAg levels
2024 · Dereck Tait, Louise Bussey, et al. · Journal of Hepatology
Abstract A101: Novel KRAS inhibitors suppress MAPK pathway signalling and display potent anti-proliferative activity across a broad range of KRAS mutant cell lines
2023 · Inder Bhamra, Helen Mason, et al. · Molecular Cancer Therapeutics
665 Immunotherapeutic trial in men with biochemical recurrence after definitive local therapy for prostate cancer: A clinical trial in progress
2023 · Mark N Stein, Jessica Hawley, et al. · Journal for ImmunoTherapy of Cancer
PDF
Melanoma displays an evolutionarily conserved resistance to modulation of phagocytic signals
2017 · Katie Anderson · University of Minnesota Digital Conservancy (University of Minnesota)
C3a-C3aR interaction regulates the allostimulatory function of dendritic cells
2007 · Wuding Zhou, Qi Peng, et al. · Research Portal (King's College London)
Production of C3 by DCs modulates their capacity for antigen uptake and processing
2006 · Katie Anderson, Ke Li, et al. · Molecular Immunology
Exploration of mechanisms by which production of C3 by DCs upregulates their potency to stimulate T cells
2005 · Katie Anderson, Qi Peng, et al. · Research Portal (King's College London)
Works count: 24
Citation count: 811
H-index: 9
I10-index: 9
Year
Topic
Type